Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

COMMISSARIAT A L' ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

UEI: W1BNGDFSXD75CAGE: F6258

COMMISSARIAT A L' ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES is a federal contractor, registered under UEI W1BNGDFSXD75 and CAGE code F6258. It has been awarded $4,141,036 across 13 federal contracts. Primary work spans Unknown NAICS and Research and Development in Biotechnology. Top awarding agencies include Department Of Defense, Agency For International Development (usaid), and Department Of Health And Human Services (hhs).

Contact Information

Registration and classification details

Address123 Main St, City, ST 12345

Registration

UEI Code

W1BNGDFSXD75

CAGE Code

F6258

Entity Structure

Other

Established

N/A

Business Classifications

20A8

NAICS Codes

541380Testing Laboratories and Services(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

The Commissariat à l’Énergie Atomique et aux Énergies Alternatives is a research and development organization focused on nuclear energy, renewable technologies, and advanced scientific instrumentation. Its core capabilities center on high-energy physics, radiation detection systems, nuclear safety m...

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Defense$3.6M87%

Agency For International Development (usaid)$214.2K5.2%

Department Of Health And Human Services (hhs)$214.1K5.2%

Department Of Energy (doe)$174.9K4.2%

Awards by NAICS

- Unknown NAICS$2.2M52.1%

541711 - Research and Development in Biotechnology$2.0M47.9%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in COMMISSARIAT A L' ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES's top NAICS codes and agencies

DDDPlus Software Licensing and SupportThe contract entails the provision of five individual Standard licenses for DDDPlus software, covering full delivery, installation, and compatibility testing to ensure seamless integration with existing systems. License administration will be maintained throughout a four-year term, including ongoing support and compliance management. The work is performance-based with the place of performance located in Silver Spring, Maryland, under a subcontract structure, and falls under the NAICS code 511210 for software publishing. The Department of Health and Human Services is the contracting organization, with a response deadline set for August 14, 2026, and the solicitation was posted on August 4, 2026. All activities must align with federal procurement standards and deliverables must meet technical and operational requirements specified in the agreement.

Department Of Health And Human Services

POSTED

DEADLINE

GastroPlus Software Licensing and SupportThe contract awards the supply and ongoing support of 20 Standard licenses for GastroPlus software over a four-year period, encompassing full delivery, installation, and verification of compatibility with FDA systems. The provider is responsible for ensuring seamless integration into existing infrastructure and managing all aspects of license administration throughout the term. Performance is required to occur at the designated location in Silver Spring, Maryland, with the work falling under NAICS code 511210 for software publishing. The opportunity was posted on August 4, 2026, and responses are due by August 14, 2026, with the contracting entity being the Department of Health and Human Services. This subcontract supports critical regulatory and scientific operations that rely on GastroPlus for pharmacokinetic and pharmacodynamic modeling within federal health and safety contexts.

Department Of Health And Human Services

POSTED

DEADLINE

Notice of Sole Source: GastroPlus PBPK and PBBM modeling platform subscription

Solicitation # 7571TE26Q00153

The U.S. Food and Drug Administration, through the Department of Health and Human Services, intends to sole-source a firm fixed-price contract to Simulations Plus Inc. for twenty GastroPlus and five DDDPlus software licenses, used for physiologically based pharmacokinetic and physiologically based biopharmaceutics modeling in support of generic drug research. The contract spans a base year from September 1, 2026, to August 31, 2027, with up to three one-year option periods extending through August 31, 2030. Performance will occur at the FDA’s White Oak campus in Silver Spring, Maryland. The acquisition is conducted under RFO 12, allowing for non-competitive procurement of commercial products, and no set-aside applies. Responses are due by August 14, 2026, and any interested party may submit a capability statement to demonstrate their ability to supply the exact software licenses as the original equipment manufacturer or authorized reseller, which the government will review solely to determine whether competitive procurement is warranted. The contract requires the vendor to provide standard individual licenses, with no auto-renewals permitted unless explicitly authorized. Acceptance of deliverables will be conducted by the Contracting Officer’s Representative within 30 working days of delivery, verifying software functionality, compatibility with FDA systems, and compliance with technical requirements. Invoicing must be submitted electronically through the Treasury’s Invoice Processing Platform, and all invoices must include detailed supporting documentation for labor, materials, and costs. The government retains the right to reject nonconforming deliveries and will not pay for services that fail to meet agreed standards. Clauses from the FAR and HHSAR govern payment, representation, whistleblower rights, anti-lobbying, accessibility, and dispute resolution, with federal regulations taking precedence over any vendor terms. The Contracting Officer and Contract Specialist are the primary points of contact, and all vendors must be actively registered in SAM at the time of submission.

Department Of Health And Human Services

POSTED

DEADLINE

PEO-M Unmanned Surface Vehicle (USV) Poseidon's Fury Collaboration Event (CE)

Solicitation # PEO_M_USV_Poseidon_s_Fury_CE

SOFWERX and the USSOCOM Program Executive Office Maritime (PEO-M) are hosting the Poseidon’s Fury Collaboration Event to accelerate the development of the Unmanned Surface Vehicle Mission-Aligned Reference Architecture (MARA), a standards-based framework designed to improve interoperability across Joint Force manned and unmanned maritime systems while eliminating redundant, service-specific platform development. This initiative is open exclusively to U.S. persons and involves a two-phase process beginning with a virtual collaboration event on August 26, 2026, where SOF operators and industry partners will engage in breakout sessions to define operational needs around user interface, autonomy, command and control, and platform effectiveness. Participation in this event is optional but strongly encouraged to align solutions with warfighter requirements, with registration closing August 14, 2026. Those who do not attend the CE may still submit capabilities for consideration during the Assessment Event, which opens on September 14, 2026, and closes October 2, 2026. A virtual Q&A session is available on September 23 for clarification on technical expectations. Selected submissions will undergo a downselect process, with winners invited to participate in a comprehensive on-water Assessment Event at Stennis Space Center, Mississippi, between November 2 and 20, 2026. Participants must demonstrate their USV capabilities in real-world conditions, with evaluations conducted by Subject Matter Experts from USSOCOM, JHU APL, WARCOM, and MARSOC using predefined technical and operational criteria. Successful performers may be transitioned to Phase 5, where potential pathways for follow-on acquisition include Other Transaction Authorities (OTAs) under 10 U.S.C. §4022, research agreements under 15 U.S.C. §3715, cooperative R&D agreements, experimental procurement under §4023, or prize competitions—potentially leading to non-competitive production awards based on successful prototype outcomes. All awardees must comply with NIST SP 800-171 for securing Controlled Unclassified Information, and eligibility is limited to U.S. persons and organizations capable of supporting USSOCOM’s unique maritime missions.

Department Of Defense

POSTED

DEADLINE

In Vitro ADMET AssaysThe contract titled In Vitro ADMET Assays calls for the performance of high-throughput in vitro screening focused on metabolic stability, hepatotoxicity, CYP450 enzyme interactions, and cellular permeability to support early-stage drug development. These assays are critical for evaluating the absorption, distribution, metabolism, excretion, and toxicity profiles of potential therapeutic candidates, enabling informed decisions before advancing compounds into costly clinical stages. The work will be conducted to meet the specific needs of the National Institutes of Health NIDA under the Department of Health and Human Services, with performance expected to occur in Bethesda. This is a subcontract opportunity under NAICS code 541711, which classifies it as research and development in the physical, engineering, and life sciences. The solicitation was posted on August 3, 2026, with a response deadline of August 18, 2026, at 7:00 PM Eastern Time. There is no set-aside classification specified, and no point of contact or detailed office address is provided in the data. Interested parties must submit their proposals before the deadline to be considered for award, with the expectation that the selected contractor will deliver reliable, scalable, and scientifically rigorous ADMET data to guide NIDA’s research initiatives in drug development.

National Institutes Of Health Nida

POSTED

DEADLINE

Genotoxicity and Carcinogenicity TestingThe contract seeks to perform in vitro and in vivo assays to assess the mutagenic and carcinogenic risks of drug candidates, ensuring compliance with regulatory safety standards for pharmaceutical development. The work is critical for identifying potential genetic toxicity and cancer-causing properties early in the drug evaluation process to support regulatory submissions and public health safeguards. The solicitation is issued as a subcontract under the National Institutes of Health NIDA, part of the Department of Health and Human Services, with performance expected to take place in Bethesda. It falls under the NAICS code 541711 for research and development in the physical, engineering, and life sciences. The proposal must be submitted by August 18, 2026, with the opportunity posted on August 3, 2026. No set-aside provisions are specified, and the contract is open to qualified subcontractors with the technical capacity to deliver high-quality genotoxicity and carcinogenicity testing services.

National Institutes Of Health Nida

POSTED

DEADLINE

Safety Pharmacology (CNS, Cardiovascular, Pulmonary)The contract requires comprehensive safety pharmacology studies to evaluate adverse effects on the central nervous system, cardiovascular system, and pulmonary function, ensuring alignment with ICH safety guidelines. The work will involve detailed pharmacodynamic assessments to identify and characterize potential risks to major organ systems during early drug development, with a focus on identifying safety signals that could impact clinical translation. This subcontract, issued by the National Institutes of Health’s NIDA under the Department of Health and Human Services, is set to be performed in Bethesda and has a response deadline of August 18, 2026. The effort is classified under NAICS code 541711, indicating it pertains to research and development in the life sciences, and is aimed at supporting regulatory-compliant preclinical safety evaluations essential for pharmaceutical advancement.

National Institutes Of Health Nida

POSTED

DEADLINE

Toxicity Testing (Acute, Subacute, Subchronic, Chronic)The contract requires the performance of comprehensive toxicity testing in both rodent and non-rodent models to assess organ toxicity and establish safety margins for submission to regulatory authorities as part of an Investigational New Drug application. The scope includes acute, subacute, subchronic, and chronic studies designed to evaluate the potential adverse effects of pharmaceutical compounds across a range of exposure durations and dosages. The work must meet rigorous scientific standards to support regulatory filings and ensure the safety profile of investigational drugs is adequately characterized prior to human trials. This subcontract is issued under the National Institutes of Health, National Institute on Drug Abuse, within the Department of Health and Human Services, with the performance location specified as Bethesda. The North American Industry Classification System code 541711 identifies the work as research and development in the life sciences. The solicitation was posted on August 3, 2026, with a mandatory response deadline of August 18, 2026, at 7:00 PM. No set-aside provisions are specified, and the contract opportunity is open to eligible contractors capable of executing preclinical toxicology studies to support IND submissions.

National Institutes Of Health Nida

POSTED

DEADLINE

In Vivo Pharmacokinetic StudiesThe contract seeks to perform in vivo pharmacokinetic studies to assess the absorption, distribution, metabolism, and excretion of a drug candidate in both rodent and non-rodent species across multiple administration routes, with the goal of generating data to support an Investigational New Drug application. These studies will evaluate drug exposure over time to establish pharmacokinetic profiles critical for regulatory submission, requiring rigorous experimental design, appropriate species selection, and adherence to good laboratory practices. All work must be completed to ensure high-quality, reproducible results that meet FDA expectations for preclinical development. The solicitation is classified as a subcontract under NAICS code 541711, issued by the National Institutes of Health through the National Institute on Drug Abuse, part of the Department of Health and Human Services. Performance is expected to take place in Bethesda, and interested parties must submit their responses no later than August 18, 2026, at 7:00 PM. The opportunity was posted on August 3, 2026, and is open for competitive bidding with no specific set-aside designation. The contract does not provide a point of contact, and all inquiries must be directed through the official SAM.gov portal linked in the posting.

National Institutes Of Health Nida

POSTED

DEADLINE

Unable to Decompose Subcontract OpportunitiesDue to a system error, the prime contract details necessary to identify or structure subcontract opportunities could not be retrieved, rendering all subcontracting analysis unavailable at this time. The solicitation is designated as a subcontract under the Department of Health and Human Services, with a posted date of August 3, 2026, and a response deadline of August 18, 2026. The place of performance is listed as Bethesda, Maryland, with a zip code of 20892, though no specific office address, point of contact, or set-aside information is provided. The NAICS code is marked as NA, and the agency and organizational designations are identical, indicating an internal system limitation. Despite the absence of actionable data for suppliers, the opportunity remains live in the system with a public view link available for reference.

Department Of Health And Human Services

POSTED

DEADLINE

Antioxidant Therapy for Smith-Lemli-Opitz Syndrone

Solicitation # NICHD-08610

The contract pertains to the development and implementation of antioxidant therapy for Smith-Lemli-Opitz Syndrome, a rare genetic disorder characterized by multiple congenital anomalies and metabolic dysfunction. The solicitation, issued under NICHD-08610 by the Department of Health and Human Services through its National Institutes of Health, invites proposals aimed at advancing targeted antioxidant interventions to mitigate the pathological effects of the condition. The opportunity was posted on August 3, 2026, with responses due by August 18, 2026, at 2:00 PM Eastern Time. The work is expected to be performed in Bethesda, Maryland, consistent with the research infrastructure of the NIH campus. All proposals must be submitted through the SAM.gov portal and should address scientific rigor, feasibility, and potential clinical impact. The primary point of contact for inquiries is Niamh Cawley, with Chung Huang as the secondary contact, both reachable via NIH email addresses. The contracting activity falls under the Department of Health and Human Services with no set-aside provisions specified, and no NAICS code is assigned, indicating flexibility in contractor categorization. Interested parties should ensure adherence to deadlines and submission requirements outlined on the official UI link linked in the posting.

Department Of Health And Human Services

POSTED

DEADLINE

Influenza Vaccine Clinical Trial ManagementThe contract pertains to the design and management of Phase I–III clinical trials for influenza vaccines, encompassing all critical aspects from protocol development and site selection to patient recruitment and regulatory reporting to the FDA. The work requires specialized expertise in infectious disease trials, with a focus on ensuring compliance with regulatory standards and timely submission of clinical data. The performance location is in Washington, DC, with a zip code of 20024, indicating the primary operational base for trial oversight and coordination. This is a subcontract under the Department of Health and Human Services, specifically managed by Barda – ASPR / DAAPPO / Barda DCMA, with a NAICS code of 541711 indicating scientific research and development services. The opportunity was posted on July 30, 2026, with a response deadline of August 15, 2026, at 9:00 PM ET. While no set-aside type or point of contact is specified, the emphasis on end-to-end clinical trial management suggests the subcontractor must possess a proven track record in vaccine development, regulatory engagement, and multi-site trial execution under federal health security initiatives.

Barda - Aspr / Daappo / Barda Dcma

POSTED

DEADLINE

Notice of Intent / Sole Source Solid Waste

Solicitation # 75H71026Q00223

The Navajo Area Indian Health Service, Shiprock Service Unit, intends to award a sole-source, firm-fixed-price contract to Navajo Sanitation for solid waste collection services at the Dzilth-Na-O-Dith-Hle Health Center in Bloomfield, New Mexico, with performance beginning September 1, 2026, and ending August 31, 2027. The procurement is justified under unusual and compelling urgency due to the contractor’s unique, uninterrupted history of providing essential waste management services at the facility, ensuring continuity of operations critical to patient care. The North American Industry Classification System code is 562111, with a small business size standard of $47 million in annual revenue. No competitive solicitation will be issued unless a respondent submits clear and convincing evidence that competition would benefit the government. Responses must be submitted in writing as a capability statement by August 17, 2026, at 10:00 a.m. MST, and must not include proprietary, classified, confidential, or sensitive information. The government is not obligated to respond to or acknowledge submissions, and failure to receive affirmative responses will result in contract award without further notice. All information provided may be used in future solicitations if competition is pursued, and any resulting solicitation will be publicly announced on SAM.gov. The point of contact for inquiries is Ken Parrish, Purchasing Agent, reachable at ken.parrish@ihs.gov.

Department Of Health And Human Services

POSTED

DEADLINE

Clinical Trial Design and Efficacy Data GenerationThe contract calls for the design and execution of clinical trials aimed at evaluating the safety, wound closure, infection control, and functional regeneration outcomes of medical interventions in patients with burn and trauma injuries. The work requires rigorous scientific methodology to generate robust efficacy data that supports regulatory and clinical adoption, with a focus on measurable endpoints related to tissue recovery and patient outcomes. The trials must be conducted in accordance with established clinical standards and are intended to provide evidence of therapeutic effectiveness under real-world conditions. This is a subcontract under the Aspr Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services, with a solicitation posted on July 28, 2026, and a response deadline of August 28, 2026. The work is classified under NAICS code 541711, indicating research and development in the life sciences. The performance location is designated with a zip code of 77416, though no specific city or state is provided, and no point of contact details are listed. The contract does not include a set-aside designation, and all eligible entities may respond, with emphasis placed on technical capability, trial design expertise, and experience in trauma and burn clinical research.

Aspr Administration For Strategic Preparedness And Response

POSTED

DEADLINE

MARSOC: Automated Armory Collaboration Event (CE)

Solicitation # MARSOC_Automated_Armory_CE

MARSOC, in partnership with SOFWERX, is inviting U.S. industry, academia, and national laboratories to collaboratively develop a revolutionary automated armory system that eliminates manual inventory processes through a fully passive, image-based tracking solution. The initiative targets the modernization of serialized weapon and equipment accountability by replacing paper logs, handwritten forms, and RFID or radio-frequency systems with secure optical recognition and computer vision technologies. Participants are challenged to design a system that authenticates users via CAC, automatically logs equipment issuance and recovery through photographic scans, tracks item locations, and maintains tamper-proof audit trails—all without emitting any RF signals to preserve operational security. The effort is driven by the need to reduce human error, minimize administrative burden, and ensure absolute accountability in high-stakes special operations environments. The collaboration unfolds in stages: first, a mandatory submission deadline of 16 August 2026 for attendance at the in-person Collaboration Event on 17 September 2026 at SOFWERX in Florida, where stakeholders will engage directly with warfighters to refine requirements. Those unable to attend may still submit solutions by 20 October 2026 for the Assessment Event, which includes a virtual Q&A on 3 November and a downselect by 1 December. Finalists will present live demonstrations during the Assessment Event from 15 to 17 December 2026, with top-performing solutions potentially entering into non-traditional agreements under 10 U.S.C. Sections 4021, 4022, or other alternative contracting authorities such as OTAs, CRADAs, or prize competitions. Selected participants must comply with NIST SP 800-171 for handling Controlled Unclassified Information. Only U.S. persons and U.S. industry entities are eligible to participate, and success in this event may lead directly to follow-on production agreements without additional competition.

Department Of Defense

POSTED

DEADLINE

Induced Pluripotent Stem Cell (iPSC) Reprogramming ServicesThe contract entails the reprogramming of human articular chondrocytes and bone marrow cells into induced pluripotent stem cells using Sendai virus technology, with full support for culture expansion and cryopreservation of the resulting iPSCs. This subcontract is part of a research initiative led by the Department of Veterans Affairs through Rpo East, focused on advancing regenerative medicine techniques through advanced cellular reprogramming methods. The work requires precise adherence to protocols ensuring high efficiency, safety, and scalability of iPSC generation while maintaining cell viability and pluripotency throughout the process. The solicitation is open for responses until August 6, 2026, and falls under NAICS code 541711, indicating it is for research and development in the biological sciences. The agreement is structured as a subcontract, suggesting it will be awarded to a specialized contractor with expertise in stem cell biology and virology-based reprogramming. Performance is expected to meet rigorous quality standards for cellular products intended for potential therapeutic or diagnostic applications, with an emphasis on reproducibility and documentation. All deliverables must include verified iPSC lines archived through cryopreservation, ready for downstream use in future studies or clinical translation.

Rpo East (36C24E)

POSTED

DEADLINE

in about 13 hours

Contactless Iris Collection Collaboration Event

Solicitation # Contactless_Iris_Collection_Collaboration_Event

The U.S. Special Operations Command Program Executive Office for Tactical Information Systems, in partnership with SOFWERX, is conducting a structured initiative to evaluate the feasibility of using commercially available Android-based mobile devices for contactless iris image capture—without supplemental hardware—to meet biometric collection standards for integration into the Automated Biometric Identification System. This effort targets the validation of native mobile camera performance under public optical specifications against ISO and DoD biometric standards, aiming to reduce size, weight, and power requirements by leveraging built-in device lighting, including near-infrared wavelengths between 805 nm and 1,000 nm. To support this goal, a Collaboration Event is scheduled for 30 September 2026 at SOFWERX in Florida, limited to U.S. citizens and requiring registration by 28 August 2026. The event will facilitate direct engagement between warfighters and technology providers, enabling feedback loops on operational requirements and problem-solving, and is designed to prepare participants for the upcoming Assessment Event. Following the Collaboration Event, a submission window for the Assessment Event will open from 27 October to 27 November 2026, during which participants may submit their technologies for technical evaluation. A virtual Q&A session is scheduled for 11 November to clarify requirements. Submissions will be assessed on technical merit, with selected candidates invited to the Assessment Event on 19–21 January 2026, where they will present and demonstrate their solutions to an evaluation panel. Successful technologies may lead to negotiated awards under non-FAR authorities such as Other Transaction Authorities (10 U.S.C. §§ 4021, 4022), Cooperative Research and Development Agreements, or Business-to-Business agreements via SOFWERX’s Partnership Intermediary Agreement, with the potential for follow-on production without recompetition if prototype goals are met. Awardees must comply with NIST SP 800-171 standards for protecting Controlled Unclassified Information, and solutions must demonstrate significant matching scores across diverse populations, device-specific performance metrics, and reliable performance with unmodified consumer hardware.

Department Of Defense

POSTED

DEADLINE

4th Psychological Operations Group (4 POG)

Solicitation # 4_POG_event

The U.S. Special Operations Command’s 4th Psychological Operations Group, in partnership with SOFWERX, is seeking innovative software solutions to develop a unified, AI-enabled platform that integrates existing tools used for information dissemination and influence operations. This initiative aims to replace fragmented systems with a single, streamlined dashboard tailored to the operational needs of psychological operations personnel, enhancing efficiency and effectiveness across the full spectrum of mission workflows. Participation is open exclusively to U.S. citizens from industry, academia, and national laboratories, with a mandatory deadline of 5 August 2026 to request attendance at the Collaboration Event scheduled for 23–24 September 2026 at Smith Lake Recreational Center in North Carolina. The event will include structured breakout sessions to define problem sets and an optional industry expo to showcase technologies, enabling direct engagement with warfighters and potential collaborators. Following the Collaboration Event, a formal Assessment Event (AE) will open for submissions on 19 October 2026, with a virtual Q&A session on 4 November 2026 to clarify requirements. Submissions will be evaluated on technical merit, with selected participants invited to present their solutions during the AE from 12–14 January 2027. Successful candidates may be offered follow-on agreements under non-FAR authorities including Other Transaction Agreements (OTAs) under 10 U.S.C. § 4022, research and development partnerships via SOFWERX’s Partnership Intermediary Agreement, or other authorized mechanisms such as Cooperative Research and Development Agreements or prize competitions. Award recipients will be required to comply with NIST SP 800-171 standards for safeguarding Controlled Unclassified Information. Responses must be submitted by 5 August 2026 to secure entry into the process, with further instructions and criteria to be published closer to the AE submission window.

Department Of Defense

POSTED

DEADLINE

in about 3 hours